Search - tctmd.com

Displaying 161 - 180 of 385

Sort: Relevancy | Date

Presentation TVT 2017

Potential Barriers to Adopting a Minimalist Transfemoral TAVR Pathway: Emerging Solutions and Future Directions (3M Trial Updates)

Presenter: Axel Linke, Bernard Prendergast, David A. Wood

June 16, 2017

Presentation TVT 2017

Evolut R Snapshots I - The New Evolut R PRO System

Presenter: John K. Forrest

June 16, 2017

Presentation TVT 2017

The Evolut R TAVR System: A Cool Case, New Technology (Including 34mm), and Clinical Program Updates

Presenter: Jeffrey J. Popma

June 16, 2017

Presentation TVT 2017

Featured Lecture: The Spectrum of Bioprosthetic Valve Leaflet Thrombosis: From "Subclinical" Leaflet Thickening to Hemodynamic Changes and Clinical Events

Presenter: David W.M. Muller, Lars Sondergaard

June 16, 2017

Presentation TVT 2017

A Step-by-Step Analysis of the Minimalist TAVR Clinical Care Pathway: Components, Execution, and Advantages

Presenter: Axel Linke, Bernard Prendergast, Vinod H. Thourani

June 16, 2017

Presentation TVT 2017

Early Feasibility Studies in the U.S. With a Focus on Valvular Heart Disease: Updates, Impact, and Future Directions

Presenter: John G. Webb, Robert B. Hance

June 16, 2017

Presentation TVT 2017

The TAVR Stroke Manifesto Changing Frequency, Comparison With SAVR, Diagnosis and Treatment in the Modern Era, and Use of Cerebral Protection

Presenter: Axel Linke, Jeffrey J. Popma, Samir R. Kapadia

June 15, 2017

Presentation TVT 2017

A Critical Appraisal of SENTINEL

Presenter: Axel Linke, Jeffrey J. Popma, Saif Anwaruddin

June 15, 2017

Presentation TVT 2017

The SENTINEL Trial: Safety and Effectiveness of Cerebral Embolic Protection During TAVR

Presenter: Axel Linke, Jeffrey J. Popma, Susheel Kodali

June 15, 2017

Presentation TVT 2017

A Synthesis of the Various TAVR Systems: Should Clinical and Anatomic Factors Determine TAVR Device Selection?

Presenter: Axel Linke, Jeffrey J. Popma

June 15, 2017

Presentation TVT 2017

A Critical Appraisal of REPRISE III

Presenter: Axel Linke, Jeffrey J. Popma, Raj Makkar

June 15, 2017

Presentation TVT 2017

The REPRISE III LBCT: A Randomized Trial Comparing LOTUS vs Self-Expanding CoreValve in High-Risk Aortic Stenosis Patients

Presenter: Axel Linke, Jeffrey J. Popma, Michael J. Reardon

June 15, 2017

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

Presentation TVT 2017

Apical Access Surgical Technique: TAVR vs TMVR

Presenter: Brian K. Whisenant, Hendrik Treede

June 15, 2017

Presentation TVT 2017

Techniques for Trans-septal Valve-in-Ring, Valve-in-Valve, and Valve-in-MAC

Presenter: Brian K. Whisenant, Mayra Guerrero

June 15, 2017

Presentation TVT 2017

The Imaging Conundrum of Bicuspid Aortic Valve Disease - Almost 50 Shades of Gray!

Presenter: Robert O. Bonow, Martin B. Leon, Nicolo Piazza

June 15, 2017

Presentation TVT 2017

Classification of Aortic Stenosis Based Upon the Extent of Cardiac Damage A Novel Concept

Presenter: Robert O. Bonow, Martin B. Leon, Philippe Généreux

June 15, 2017

Presentation TVT 2017

Selecting Patients for ViV and ViR: Can We Predict Success and Complications?

Presenter: Saibal Kar, Danny Dvir

June 15, 2017

Presentation TVT 2017

Spotlight Lecture: The Rapid Emergence of TAVR Programs in Japan - The OCEAN-TAVI Registry

Presenter: Robert O. Bonow, Martin B. Leon, Kentaro Hayashida

June 15, 2017

Presentation TVT 2017

The Rationale and Need for a Tiered National System of Valve Centers Controversies and Proposed Programs

Presenter: Robert O. Bonow, Martin B. Leon, Michael J. Mack

June 15, 2017

Advertisement

Potential Barriers to Adopting a Minimalist Transfemoral TAVR Pathway: Emerging Solutions and Future Directions (3M Trial Updates)

Evolut R Snapshots I - The New Evolut R PRO System

The Evolut R TAVR System: A Cool Case, New Technology (Including 34mm), and Clinical Program Updates

Featured Lecture: The Spectrum of Bioprosthetic Valve Leaflet Thrombosis: From "Subclinical" Leaflet Thickening to Hemodynamic Changes and Clinical Events

A Step-by-Step Analysis of the Minimalist TAVR Clinical Care Pathway: Components, Execution, and Advantages

Early Feasibility Studies in the U.S. With a Focus on Valvular Heart Disease: Updates, Impact, and Future Directions

The TAVR Stroke Manifesto Changing Frequency, Comparison With SAVR, Diagnosis and Treatment in the Modern Era, and Use of Cerebral Protection

A Critical Appraisal of SENTINEL

The SENTINEL Trial: Safety and Effectiveness of Cerebral Embolic Protection During TAVR

A Synthesis of the Various TAVR Systems: Should Clinical and Anatomic Factors Determine TAVR Device Selection?

A Critical Appraisal of REPRISE III

The REPRISE III LBCT: A Randomized Trial Comparing LOTUS vs Self-Expanding CoreValve in High-Risk Aortic Stenosis Patients

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Apical Access Surgical Technique: TAVR vs TMVR

Techniques for Trans-septal Valve-in-Ring, Valve-in-Valve, and Valve-in-MAC

The Imaging Conundrum of Bicuspid Aortic Valve Disease - Almost 50 Shades of Gray!

Classification of Aortic Stenosis Based Upon the Extent of Cardiac Damage A Novel Concept

Selecting Patients for ViV and ViR: Can We Predict Success and Complications?

Spotlight Lecture: The Rapid Emergence of TAVR Programs in Japan - The OCEAN-TAVI Registry

The Rationale and Need for a Tiered National System of Valve Centers Controversies and Proposed Programs

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content